Rezultati pretraživanja
  1. prije 14 sati
  2. prije 19 sati

    Key binary events in Feb '20 from Cowen

  3. 5. velj

    A selection of expected catalysts this month courtesy of Cowen

  4. 3. velj

    Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates

  5. 3. velj

    Covered (-3.4%). 132% long by 28% short. 33% long Technology, 32% long Health Care, 14% long Finance, 10% long Consumer Services.

  6. 2. velj
  7. 1. velj

    Chardan Capital Reaffirms Hold Rating for Esperion Therapeutics

  8. 31. sij

    : New SEC Filing for ESPR: Form 8-K (No. 0001104659-20-009245):

  9. 31. sij
  10. 31. sij

    The CHMP recommended granting marketing authorisations for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid / ezetimibe) for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia

  11. 31. sij
  12. 30. sij

    lots of volatility on no news?

  13. 30. sij

    Esperion Therapeutics Shares Up 5.4% Following Insider Buying Activity

  14. 30. sij

    Short sale volume (not short interest) for at 2020-01-29 is 54%. 26% 60% 58% 58%

  15. 29. sij

    Is approval priced in?

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.